$1.15
+0.04 (+3.60%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+2,495.7% upside
Low Target
$17.55
Average Target
$29.85
High Target
$40.51
Current Price
$1.15
Current
$1.15
$1.15
Target
$29.85
$29.85
$17.55
$29.85 avg
$40.51
Scenario Analysis
Bear Case
$17.55
1,426.1%
Low target
Base Case
$29.85
+2,495.7%
Avg target
Bull Case
$40.51
+3,422.6%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$7.60
-84.9% from high
52-Week Low
$1.07
+8.0% from low
Target vs 52W High
$29.85
+292.8% vs high
Next Earnings Report
Nov 23, 2026 · After Market Close
14d
until earnings
EPS Est: $-0.11
Earnings in 14 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 32% | $149.45 | -41.2% |
| REGN | Buy | 36 | 72% | $76.80 | -91.5% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -40.7% |